scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Nippon India NIFTY Pharma ETF Growth Plan

Feedback
Nippon India NIFTY Pharma ETF Growth Plan

Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) Share Price

  • Sector: ETF ()
  • Volume: 1,336,136
Mar 07, 2025 15:59 IST-
  • NSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹20.79
₹0.03 (0.14%)
₹20.74 Low
Today’s Performance
₹20.99 High
₹17 Low
52 Week’s Performance
₹24.65 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -0.14%
  • 1 Week 2.82%
  • 1 Month -7.56%
  • 3 Months -8.70%
  • 6 Months -11.57%
  • 1 Year 6.62%
  • 3 Years 18.26%
  • 5 Years 0.00%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.56
  • 52-Week Low (₹) 12.22
  • 52-Week High (₹) 20.80
  • Price-to-Book (X)* 1.84
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* 0.00
  • Earnings Per Share (₹) 0.00
  • Sector Price Earning (X)* 0.00
  • Market Cap (₹ Cr.)* 639.01
  • * Vaues as of last close price

COMPETITORS

  • Records not found!!!

BT TV

BT TV Excl, MCA Secretary On PM Internship Scheme’s Impact 19:41 BT TV Excl, MCA Secretary On PM Internship Scheme’s Impact
Designer Rahul Mishra Decodes The Importance Of Handmade, Heritage-Driven Fashion In AI Era 1:48 Designer Rahul Mishra Decodes The Importance Of Handmade, Heritage-Driven Fashion In AI Era
India Today Conclave: Despite IT Talent, Why Has India Not Created Its Own DeepSeek? 2:36 India Today Conclave: Despite IT Talent, Why Has India Not Created Its Own DeepSeek?
India's Sovereign AI: Why India Must Manufacture Intelligence, Not Just Rely on Global Models! 2:47 India's Sovereign AI: Why India Must Manufacture Intelligence, Not Just Rely On Global Models!
Telangana CM Revanth Reddy: Need A National Consensus To Lower The Fiscal Burden Of Political Sops 4:47 Telangana CM Revanth Reddy: Need A National Consensus To Lower The Fiscal Burden Of Political Sops
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.

No Data For Bulk Deal.

*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Nippon India NIFTY Pharma ETF Growth Plan share price previously?
Nippon India NIFTY Pharma ETF Growth Plan share price was down by -0.14% from the previous closing price of ₹20.82.
Who are peers of Nippon India NIFTY Pharma ETF Growth Plan?
The peers of Nippon India NIFTY Pharma ETF Growth Plan are
Who is/are the promoter/promoters of Nippon India NIFTY Pharma ETF Growth Plan?
The promotor/promotors of Nippon India NIFTY Pharma ETF Growth Plan are
What has been 52-week high of Nippon India NIFTY Pharma ETF Growth Plan stocks?
The highest price of Nippon India NIFTY Pharma ETF Growth Plan stock is ₹24.65 in the last 52-week.
What is the share price of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) today on NSE?
As on Mar 07, 2025, Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES)’s share price on NSE is Rs 20.79
What is the market cap of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES?)
The current market capitalisation of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) is 639.01 crores
What is Nippon India NIFTY Pharma ETF Growth Plan Share symbol?
The symbol of Nippon India NIFTY Pharma ETF Growth Plan is PHARMABEES.
What is the PE ratio of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES)?
The current PE ratio of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) is 0.00.
What is the PB ratio of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES)?
The current PB ratio of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) is 1.84.
Today’s High & Low share prices of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) on NSE?
Today, the share price of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) on NSE touched a high of Rs 20.99 and a low of Rs 20.74
What price did Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) shares open on the NSE today?
On NSE, the share price of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) opened at Rs 20.9
What is the 52-week high of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES)?
The 52-week high price of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) is Rs 24.65
What is the 52-week low of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) ?
The 52-week low price of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) is Rs 17

ABOUT NIPPON INDIA NIF

Nippon India NIFTY Pharma ETF Growth Plan, incorporated in the year , has its registered office in 4th Floor Tower A Peninsula Bu, Ganapatrao Kadam Marg Lower Pa, Mumbai, Maharashtra, 400013, 91-22-6808 7000, 91-22-6808 7097. The main industry in which Nippon India NIFTY Pharma ETF Growth Plan operates is Stock Exchanges.

Auditor/Auditors for Nippon India NIFTY Pharma ETF Growth Plan is/are . In the main management, is chairman and is the company secretary for Nippon India NIFTY Pharma ETF Growth Plan.

  • No Data For About.

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement